Cooper Companies (NASDAQ:COO) Shares Gap Up Following Better-Than-Expected Earnings

Shares of The Cooper Companies, Inc. (NASDAQ:COO) gapped up prior to trading on Friday following a better than expected earnings announcement. The stock had previously closed at $62.02, but opened at $65.24. Cooper Companies shares last traded at $66.1170, with a volume of 1,427,147 shares changing hands.

The medical device company reported $1.21 earnings per share for the quarter, beating the consensus estimate of $1.10 by $0.11. The firm had revenue of $1.08 billion for the quarter, compared to analysts’ expectations of $1.05 billion. Cooper Companies had a return on equity of 10.34% and a net margin of 9.67%.The company’s revenue was up 7.9% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.96 EPS. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS.

Analyst Upgrades and Downgrades

Several research analysts have issued reports on COO shares. Piper Sandler set a $86.00 target price on Cooper Companies and gave the stock an “overweight” rating in a research report on Monday. Citigroup reiterated a “neutral” rating and issued a $69.00 price objective (down from $80.00) on shares of Cooper Companies in a research note on Thursday, May 28th. Needham & Company LLC dropped their price objective on shares of Cooper Companies from $101.00 to $86.00 and set a “buy” rating on the stock in a report on Friday. Wall Street Zen upgraded shares of Cooper Companies from a “hold” rating to a “buy” rating in a research report on Saturday, February 28th. Finally, Wells Fargo & Company reaffirmed a “sell” rating and set a $66.00 target price (down from $82.00) on shares of Cooper Companies in a report on Friday. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, six have issued a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $83.86.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in the stock. New York Life Investment Management LLC boosted its stake in Cooper Companies by 0.6% during the 4th quarter. New York Life Investment Management LLC now owns 27,344 shares of the medical device company’s stock valued at $2,241,000 after acquiring an additional 158 shares during the last quarter. Root Financial Partners LLC raised its stake in shares of Cooper Companies by 104.5% in the 4th quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock valued at $26,000 after purchasing an additional 162 shares in the last quarter. Essential Partners LLC lifted its position in shares of Cooper Companies by 23.4% during the first quarter. Essential Partners LLC now owns 874 shares of the medical device company’s stock worth $62,000 after purchasing an additional 166 shares during the last quarter. Allworth Financial LP grew its stake in Cooper Companies by 14.1% in the fourth quarter. Allworth Financial LP now owns 1,355 shares of the medical device company’s stock worth $111,000 after purchasing an additional 167 shares in the last quarter. Finally, Mesirow Financial Investment Management Inc. increased its holdings in Cooper Companies by 1.3% in the third quarter. Mesirow Financial Investment Management Inc. now owns 14,017 shares of the medical device company’s stock valued at $961,000 after buying an additional 175 shares during the last quarter. 24.39% of the stock is owned by hedge funds and other institutional investors.

Cooper Companies Price Performance

The company has a quick ratio of 0.79, a current ratio of 1.34 and a debt-to-equity ratio of 0.22. The company has a 50 day simple moving average of $65.17 and a 200-day simple moving average of $74.57. The stock has a market cap of $12.96 billion, a price-to-earnings ratio of 32.86, a PEG ratio of 1.56 and a beta of 0.87.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.